The U.S. Supreme Court ruled against the drugmaker Wyeth (WYE.N) on Wednesday, holding that pharmaceutical companies can be held liable for harm from medicines that carry warnings approved by federal regulators.
By a 6-to-3 vote in a major defeat for the pharmaceutical industry, the high court ruled that U.S. Food and Drug Administration labeling approvals do not pre-empt state laws and shield companies from damages as part of liability claims.
US Supreme Court: FDA-approved labels no legal shield
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
